| 摘要 |
Antigen binding proteins that bind &bgr;-amyloid peptide, in particular human &bgr;-amyloid peptide; methods of treating diseases or disorders characterized by elevated &bgr;-amyloid levels or &bgr;-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterized by elevated &bgr;-amyloid levels or &bgr;-amyloid deposits, including age related macular degeneration and glaucoma type diseases and &bgr;-amyloid dependent cataract formation, with the antigen binding proteins; pharmaceutical compositions comprising the antigen binding proteins; and methods of manufacture. |
